US Patent

US9987231 — Compositions and methods for delivery of omeprazole plus acetylsalicylic acid

Method of Use · Assigned to Pozen Inc · Expires 2033-01-02 · 7y remaining

Vulnerability score 62/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects a method for delivering a pharmaceutical composition containing acetylsalicylic acid and omeprazole to a patient.

USPTO Abstract

The present disclosure is directed to a method for delivering a pharmaceutical composition to a patient in need thereof, comprising: administering to said patient a pharmaceutical composition in unit dose form comprising acetylsalicylic acid, or pharmaceutically acceptable salt thereof, and omeprazole, or pharmaceutically acceptable salt thereof.

Drugs covered by this patent

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

Code	Description	Drug
`U-2324`	—
`U-2324`	—

Patent Metadata

Patent number: US9987231
Jurisdiction: US
Classification: Method of Use
Expires: 2033-01-02
Drug substance claim: No
Drug product claim: No
Assignee: Pozen Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.